Gut & MicrobiomeResearch PaperPaywall

Diet Shapes Gut Microbiome in Lynch Syndrome Patients at High Cancer Risk

Western diets reduce microbial diversity in Lynch syndrome, while plant proteins boost beneficial bacteria linked to colorectal cancer protection.

Sunday, May 31, 2026 1 views
Published in Am J Clin Nutr
A colorful spread of plant-based foods — lentils, beans, leafy greens, whole grains — alongside a stool sample collection kit on a clinical consultation desk

Summary

People with Lynch syndrome carry genetic mutations that dramatically raise their risk of colorectal and other cancers. This French study examined how diet shapes the gut microbiome in 95 Lynch syndrome patients. Researchers found that Western dietary patterns and higher red meat, saturated fat, and animal protein intakes were linked to lower gut microbial diversity — a marker of poor gut health. Conversely, plant proteins were associated with greater diversity and higher levels of a beneficial bacterial group called Lachnospiraceae NK3A20. Since gut microbiome disruption is itself linked to colorectal cancer development, these findings suggest that dietary choices may influence cancer risk in this already-vulnerable population. The study is exploratory and needs confirmation, but it points toward plant-forward diets as a potentially protective strategy for Lynch syndrome patients.

Detailed Summary

Lynch syndrome (LS) is one of the most common hereditary cancer syndromes, caused by mutations in mismatch repair genes that dramatically elevate lifetime risk of colorectal cancer (CRC) and other malignancies. While surveillance colonoscopies are the cornerstone of management, there is growing interest in modifiable lifestyle factors — particularly diet — that may shift cancer risk in this genetically predisposed population.

This cross-sectional analysis drew on participants enrolled in the AAS-Lynch clinical trial in France between 2017 and 2022. Ninety-five individuals with LS provided stool samples, completed validated food frequency questionnaires, and contributed sociodemographic and clinical data. Gut microbiota profiles were generated via 16S rRNA sequencing, and statistical models including linear regression and PERMANOVA tested associations between dietary patterns and microbiome metrics.

The results were striking in their consistency. Both alpha-diversity indices — Shannon and Simpson — were negatively associated with Western dietary patterns, red meat intake, and higher consumption of saturated fats, cholesterol, and animal proteins. Conversely, plant protein intake and a higher plant-to-animal protein ratio were positively linked to microbial diversity. When examining community composition, Western diet, fruit consumption, cakes and biscuits, breakfast cereals, and red meat emerged as the top drivers of between-individual microbiome differences. Plant protein intake was specifically linked to greater abundance of Lachnospiraceae NK3A20, a group associated with short-chain fatty acid production and gut homeostasis.

These findings carry meaningful implications. In a population already at elevated CRC risk, dietary-driven microbiome shifts could represent an additional modifiable risk factor or a protective lever. Plant-forward dietary strategies may deserve clinical attention in LS management protocols.

Important caveats apply. The cross-sectional design prevents causal inference. The sample size of 95 is modest. The summary is based solely on the published abstract, and full methodological details remain inaccessible.

Key Findings

  • Western diet and red meat intake significantly reduced gut microbial diversity in Lynch syndrome patients.
  • Plant protein intake and higher plant-to-animal protein ratios were linked to greater microbiome diversity.
  • Plant proteins specifically boosted Lachnospiraceae NK3A20, a butyrate-producing bacterial group.
  • Diet was among the top drivers of between-individual differences in microbiome composition.
  • This is the first study to characterize diet-microbiome associations specifically in Lynch syndrome.

Methodology

Cross-sectional analysis of 95 Lynch syndrome participants from the French AAS-Lynch clinical trial (2017–2022). Fecal microbiota profiled via 16S rRNA sequencing; dietary intakes assessed with a validated food frequency questionnaire. Associations tested using linear regression, ANOVA, and PERMANOVA adjusted for confounders.

Study Limitations

The cross-sectional design precludes causal conclusions about diet driving microbiome changes or cancer outcomes. The sample size of 95 limits statistical power and generalizability. This summary is based on the abstract only, as the full paper is not open access, so complete methodological and results details are unavailable.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.